Abstract:Background: Celiac Disease (CD) is an immune-mediated disorder, in which the HLA immunogenetic background (DQ2 and DQ8 heterodimers) and environmental trigger (gluten) are well established. Indeed, both factors are necessary - but not sufficient - to develop CD. However, it is very likely that CD is underdiagnosed in both developing and developed countries, due to several aspects, including the fact that a lot of patients present mild and/or atypical symptoms, without the presence of any recognized risk factors. Therefore, the possibility and feasibility of widened screening strategies to identify CD patients are debated. Aim: To provide further evidence of the main epidemiological importance of HLA-DQB1*02 allele in the population of CD patients. Methods: We performed a systematic search in PubMed, EMBASE, Cochrane, Web of Science and Scopus databases, in order to produce a systematic review assessing the carrier frequency of HLA-DQB1*02 allele in the celiac population. Following the PRISMA guidelines, we retrieved all the original articles describing CD patients' HLA-DQB1 genotype in such a way that could allow to assess the HLA-DQB1*02 carrier frequency among CD patients, along with the evidence of the appropriate diagnostic work-up to achieve a correct and final diagnosis of CD. Results: The final output of this systematic search in the medical literature consisted of 38 studies providing the appropriate HLA-DQB1 genotype information of the respective CD population. According to this systematic review, including a pool of 4945 HLA-DQ genotyped CD patients, the HLA-DQB1*02 carrier frequency was 94.94%, meaning that only 5.06% of CD patients were completely lacking this allelic variant. Interestingly, if we consider only the studies whereby the prevalence of CD patients affected with type 1 diabetes mellitus was supposed or clearly established to be very low, the frequency of non-HLA-DQB1*02 carriers among CD patients dropped to 3.65%. Conclusion: Such a high carrier frequency of the HLA-DQB1*02 allelic variant (which is > 95%-96% in CD patients without risk factors, like type 1 diabetes mellitus comorbidity) might be exploited to consider a cost-effective and widened screening approach. If a sustainable strategy could be implemented through a low-cost targeted genetic test to detect the individual presence of HLA-DQB1*02 allele, an appropriate algorithm for serological screening in individuals resulting to be genetically predisposed to CD, might be considered.

Distribution of celiac disease predisposing genes HLA-DQ2 and HLA-DQ8 in the native population of southern India

Human Leukocyte Antigen DQ (HLA-DQ) genotypes and haplotypes and their association with phenotype in patients with celiac disease in India

Genomewide Linkage Analysis of Celiac Disease in Finnish Families.

HLA-DQ Genotype Distribution and Risk Evaluation of Celiac Disease in Northwest China.

Carrier frequency of HLA-DQB1*02 allele in patients affected with celiac disease: A systematic review assessing the potential rationale of a targeted allelic genotyping as a first-line screening

"Geographical distribution of risk genotypes in pediatric patients with celiac disease in Spain"

HLA-DQ genotypes relative risks for celiac disease in Arabs: A case-control study

DQA10102 DQB10602 haplotype distinguishes coeliac disease and its complications from gluten unrelated enteropathies

High frequency of low-risk human leukocyte antigen class II genotypes in latent celiac disease

The prevalence of coeliac disease-associated human leukocyte antigens in South African transplant donors and recipients

Estimation of the celiac disease prevalence in Denmark and the diagnostic value of HLA-DQ2/DQ8

HLA Genotyping in Romanian Adult Patients with Celiac Disease, their First-degree Relatives and Healthy Persons

Genetic predisposition to celiac disease in Kazakhstan: Potential impact on the clinical practice in Central Asia

Human Leukocyte Antigen Class II Alleles in White Brazilian Patients With Celiac Disease

The Second Highest Prevalence of Celiac Disease Worldwide: Genetic and Metabolic Insights in Southern Brazilian Mennonites

Celiac disease diagnosis: transglutaminase, duodenal biopsy and genetic tests correlations

Is HLA‐DQ typing useful in screening for celiac disease among Arabs with type 1 diabetes? A case–control study

Role of HLA-DQ typing and antitissue transglutaminase antibody titres in diagnosing coeliac disease among Sudanese children with type 1 diabetes mellitus

Shared and unique common genetic determinants between pediatric and adult celiac disease

TagSNP approach for HLA risk allele genotyping of Saudi celiac disease patients: effectiveness and pitfalls

[HLA-DQ Gene and Susceptibility of Insulin Dependent Diabetes Mellitus in Chinese Population].